跳至主要内容
临床试验/NCT00934193
NCT00934193撤回3 期

Does Peri-Operative Gabapentin Reduce Chronic Post-Thoracotomy Pain?

University of Kansas Medical Center0 个研究点开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
主要终点
The primary objective of this study is to determine if gabapentin can decrease or prevent chronic post-thoracotomy pain.

研究概览

简要总结

The primary objective of this study is to determine if gabapentin can decrease or prevent chronic post-thoracotomy pain.

详细描述

This study is a prospective double blind randomized controlled trial evaluating the peri-operative use of gabapentin in the prevention or modulation of post-thoracotomy hyperalgesia. Treatment will consist of a 600 mg dose of gabapentin or placebo given preoperatively the night before surgery, based on a computer generated randomized assignment. The treatment group will continue to be medicated with gabapentin 300 mg twice daily for one month following surgery. Those not included in the treatment arm of the study will continue to take a placebo for the same duration. Follow-up will consist of a postoperative visit at approximately 48 hours and a one month clinical visit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Undergoing non-cardiac thoracic surgeries
  • Patients determined to have impaired decisional capacity with respect to the provision of informed consent or prisoners will not be included in the study.

排除标准

  • Current gabapentin use or current treatment for neuropathic pain.
  • Pregnant or considering becoming pregnant.

研究组 & 干预措施

Gabapentin

Active Comparator

干预措施: Gabapentin (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

The primary objective of this study is to determine if gabapentin can decrease or prevent chronic post-thoracotomy pain.

时间窗: 6 Months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验